A Multidrug Donor Preconditioning Improves Steatotic Rat Liver Allograft Function and Recipient Survival After Transplantation
The scarcity of donors has prompted the growing utilization of steatotic livers, which are susceptible to injuries following orthotopic liver transplantation (OLT). This study aims to assess the efficacy of multidrug donor preconditioning (MDDP) in alleviating injuries of steatotic grafts following rat OLT. Lean rats were subjected to a Western-style diet with high-fat (HF) and high-fructose (HFr) for 30 days to induce steatosis. Both lean and steatotic livers were implanted into lean recipients fed with a chow diet after OLT. The HF + HFr diet effectively elevated blood triglyceride and cholesterol levels and induced fat accumulation in rat livers. Our results demonstrated a significant decrease in alanine aminotransferase levels (<i>p</i> = 0.003), aspartate aminotransferase levels (<i>p</i> = 0.021), and hepatic Suzuki scores (<i>p</i> = 0.045) in the steatotic rat liver allograft group following MDDP treatment on post-operation day (POD) 7. Furthermore, the survival rates of steatotic rat liver allografts with MDDP (19/21, 90.5%) were significantly higher than those in the steatotic control (12/21, 57.1%, *<i>p</i> = 0.019). These findings indicate that MDDP treatment improves steatotic rat liver allograft function and recipient survival following OLT.
Authors
- Salamah Mohammad Alwahsh
- Otto Kollmar (ORCID: https://orcid.org/0000-0003-4558-4006)
- Min Xu (ORCID: https://orcid.org/0000-0002-5265-3711)
- Myung‐Ho Kim
Institutions
- Harvard University (US)
- University Hospital of Basel (CH)
- Palestine Polytechnic University (PS)
- Massachusetts General Hospital (US)
- Universitätsmedizin Göttingen (DE)
- Woosuk University (KR)
- University of Göttingen (DE)
Publication Details
- Journal
- Transplant International
- Published
- 2024-12-13
- DOI
- https://doi.org/10.3389/ti.2024.13557
- Citations
- 2
- Primary Topic
- Organ Transplantation Techniques and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.15
Funders
- Universitätsmedizin Göttingen